Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 57
(2)
◽
pp. 254
◽
2013 ◽
Vol 98
(9)
◽
pp. 3550-3554
◽
Keyword(s):